Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRAVOPROST vs TREMELIMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRAVOPROST vs TREMELIMUMAB: Safety Overview

Metric TRAVOPROST TREMELIMUMAB
Total FAERS Reports 6,455 2,387
Deaths Reported 145 594
Death Rate 2.2% 24.9%
Hospitalizations 164 1,510
Average Patient Age 71.6 yrs 64.7 yrs
% Female Patients 63.0% 31.6%
FDA Approval Date Dec 13, 2023 N/A
Manufacturer Sagent Pharmaceuticals AstraZeneca Pharmaceuticals LP
Route OPHTHALMIC INTRAVENOUS
Marketing Status Discontinued N/A